PRESS RELEASE published on 11/05/2025 at 18:19, 6 months 7 days ago SCHOTT Pharma: Christian Mias to succeed Andreas Reisse as CEO of SCHOTT Pharma Christian Mias appointed as CEO of SCHOTT Pharma, succeeding Andreas Reisse. Strategic leadership transition ensured for global pharmaceutical packaging leader Pharmaceutical SCHOTT Pharma CEO Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 6 months 7 days ago Christian Mias nommé nouveau PDG de SCHOTT Pharma SCHOTT Pharma Nomination Du PDG Changement De Leadership Christian Mias Andreas Reisse
BRIEF published on 11/05/2025 at 18:01, 6 months 7 days ago Christian Mias Appointed as New CEO of SCHOTT Pharma CEO Appointment SCHOTT Pharma Leadership Change Christian Mias Andreas Reisse
PRESS RELEASE published on 11/05/2025 at 17:56, 6 months 7 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Christian Mias to succeed Andreas Reisse as CEO SCHOTT Pharma AG & Co. KGaA appoints Christian Mias as CEO to succeed Andreas Reisse, effective May 1, 2026. Inside information disclosed. Press release via EQS News Inside Information CEO Appointment SCHOTT Pharma EQS News Christian Mias
BRIEF published on 08/12/2025 at 07:05, 9 months 1 day ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
BRIEF published on 08/12/2025 at 07:05, 9 months 1 day ago SCHOTT Pharma annonce des résultats stables au troisième trimestre 2025 Innovation SCHOTT Pharma Solutions À Haute Valeur Ajoutée Confinement Des Drogues Résultats Du Troisième Trimestre 2025
PRESS RELEASE published on 08/12/2025 at 07:00, 9 months 1 day ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
BRIEF published on 08/05/2025 at 10:00, 9 months 8 days ago SCHOTT Pharma's Q3 2025 Highlights and FY 2025 Outlook Revenue Growth EBITDA Margin Financial Outlook Q3 2025 High Value Solutions
BRIEF published on 08/05/2025 at 10:00, 9 months 8 days ago Faits marquants du troisième trimestre 2025 et perspectives pour l'exercice 2025 de SCHOTT Pharma Marge EBITDA Croissance Des Revenus Solutions À Haute Valeur Ajoutée Perspectives Financières T3 2025
BRIEF published on 08/05/2025 at 09:58, 9 months 8 days ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
Published on 05/13/2026 at 15:30, 48 minutes ago All Things Mobile Analytic, Inc. (OTCID:ATMH) Acquires Metis Technology S.p.A., Strengthening European Enterprise Capabilities
Published on 05/13/2026 at 15:05, 1 hour 13 minutes ago Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services
Published on 05/13/2026 at 15:00, 1 hour 18 minutes ago ACCESS Newswire to Present at the LD Micro Invitational XVI on May 19th, at 2:00 pm ET
Published on 05/13/2026 at 15:00, 1 hour 18 minutes ago Caldwell Announces Relaunch of Canada's Top 40 Under 40(R) Award Program
Published on 05/13/2026 at 14:35, 1 hour 43 minutes ago INEO Announces Patented INEO Welcoming DUO in Full Production with First Installation Underway in Leading UK Retailer
Published on 05/13/2026 at 16:05, 12 minutes ago PR Emerges as the Primary Source for Journalists in High-Pressure Newsrooms
Published on 05/13/2026 at 16:05, 12 minutes ago Coupa and Celonis Collaborate to Eliminate Value Leakage Across Autonomous Spend Management
Published on 05/13/2026 at 15:57, 21 minutes ago MLP SE: Invitation to the Annual General Meeting of MLP SE published
Published on 05/13/2026 at 15:45, 32 minutes ago Remission Fund Opens to Compensate Victims of the AirBit Club Fraud
Published on 05/13/2026 at 15:30, 48 minutes ago Gabler Group AG Invites to Earnings Call on Unaudited Q1 2026 Results
Published on 05/13/2026 at 16:00, 18 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 05/13/2026 at 16:00, 18 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL D'ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL
Published on 05/13/2026 at 14:31, 1 hour 46 minutes ago Statement of transactions in own shares from May 4, 2026 to May 8, 2026
Published on 05/13/2026 at 14:31, 1 hour 46 minutes ago Déclaration des transactions sur actions propres réalisées du 04/05/2026 au 08/05/2026
Published on 05/13/2026 at 12:27, 3 hours 50 minutes ago Franchisee Litigation - The Paris Court of Appeal Rules in Favor of Carrefour
